Premium
1 H‐MRSI pattern perturbation in a mouse glioma: the effects of acute hyperglycemia and moderate hypothermia
Author(s) -
Simões R.V.,
DelgadoGoñi T.,
LopePiedrafita S.,
Arús C.
Publication year - 2010
Publication title -
nmr in biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 114
eISSN - 1099-1492
pISSN - 0952-3480
DOI - 10.1002/nbm.1421
Subject(s) - ex vivo , in vivo , glioma , hypothermia , taurine , in vivo magnetic resonance spectroscopy , medicine , pathology , chemistry , endocrinology , biology , magnetic resonance imaging , cancer research , biochemistry , microbiology and biotechnology , amino acid , radiology
Abstract MR spectroscopic Imaging (MRSI), with PRESS localization, is used here to monitor the effects of acute hyperglycemia in the spectral pattern of 11 mice bearing GL261 gliomas at normothermia (36.5–37.5°C) and at hypothermia (28.5–29.5°C). These in vivo studies were complemented by ex vivo high resolution magic angle spinning (HR‐MAS) analysis of GL261 tumor samples from 6 animals sacrificed by focused microwave irradiation, and blood glucose measurements in 12 control mice. Apparent glucose levels, monitored by in vivo MRSI in brain tumors during acute hyperglycemia, rose to an average of 1.6‐fold during hypothermia ( p < 0.05), while no significant changes were detected at normothermia, or in control experiments performed at euglycemia, or in normal/peritumoral brain regions. Ex vivo analysis of glioma‐bearing mouse brains at hypothermia revealed higher glucose increases in distinct regions during the acute hyperglycemic challenge (up to 6.6‐fold at the tumor center), in agreement with maximal in vivo blood glucose changes (5‐fold). Phantom studies on taurine plus glucose containing solutions explained the differences between in vivo and ex vivo measurements. Our results also indicate brain tumor heterogeneity in the four animal tumors investigated in response to a defined metabolic challenge. Copyright © 2009 John Wiley & Sons, Ltd.